EXEL Trial readout: Monday, August 31, 2026
CompanyExelixis, Inc. (EXEL)
EventTrial readout
DateMonday, August 31, 2026
MarketUS listing
SourceCT.gov registry · confidence 50% · primary source ↗
Est. Completion: 2026-08-31. Status: ACTIVE_NOT_RECRUITING. Title: A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.